Background and aims: The integrity of motor pathways and functional connectivity patterns are important in assessing plastic changes related to successful recovery, to obtain prognostic information ...

Source Reference: Shor R, et al "Glucagon-like peptide-1 receptor agonists and risk of neovascular age-related macular degeneration" JAMA Ophthalmol 2025; DOI: 10.1001/jamaophthalmol.2025.1455.

Pyramidal tract Wallerian degeneration has been detected on magnetic resonance imaging (MRI) as T2-weighted high-intensity areas. We analyzed the relation between the extent of brain stem Wallerian ...

Degeneration : a chapter in Darwinism by Lankester, E. Ray (Edwin Ray), Sir, 1847-1929 Publication date 1880 Topics Degeneration, Evolution Publisher London : Macmillan and Co. Collection biodiversity ...

The progressive worsening of disc degeneration and related nonspecific back pain are prominent clinical issues that cause a tremendous economic burden. Activation of reactive oxygen species (ROS) ...

GLP-1 drugs like Ozempic are associated with a higher risk of developing wet age-related macular degeneration in people with type 2 diabetes, according to a new study. The risk increased the ...

Patients with diabetes who utilize glucagon-like peptide-1 receptor agonists (GLP-1 RAs) for 6 months or longer are twice as likely to develop neovascular age-related macular degeneration (AMD) as ...

A study of people with diabetes found the risk of macular degeneration remained low, but was 0.2% in people taking GLP-1s, 0.1% in those who didn't.

TOPLINE: Patients with diabetes using glucagon-like peptide 1 receptor agonists (GLP-1 RAs) may face more than twice the risk for developing neovascular age-related macular degeneration compared ...